Search results

| title = [[Humanized antibody|Chimeric + humanized]] [[monoclonal antibodies]] ("-xizu-") [[Category:Monoclonal antibody templates|{{PAGENAME}}]]

| title = [[Chimera (protein)|Chimeric]] [[monoclonal antibodies]] ("-xi-") [[Category:Monoclonal antibody templates|{{PAGENAME}}]]

| title = [[Humanized antibody|Humanized]] [[monoclonal antibodies]] ("-zu-") [[Category:Monoclonal antibody templates|{{PAGENAME}}]]

| title = [[Human]] [[monoclonal antibodies]] ("-u-") [[Category:Monoclonal antibody templates|{{PAGENAME}}]]

| group1 = [[Antibody|Antibodies]] | group1 = [[Monoclonal antibodies|Monoclonal]]

| title = [[Mouse]] [[monoclonal antibodies]] ("-o-") [[Category:Monoclonal antibody templates|{{PAGENAME}}]]

| group3 = [[CD20]] [[Monoclonal antibody|antibodies]]

...] hybrid [[monoclonal antibodies]] ([[Trifunctional antibody|trifunctional antibodies]], "-axo-") [[Category:Monoclonal antibody templates|{{PAGENAME}}]]

|topic = [[monoclonal antibodies]]

...up1 = [[Cancer immunotherapy|CI]] [[Monoclonal antibody therapy|monoclonal antibodies]] ("-mab")

...he arsenal against hypertension. Early inhibitors of renin were monoclonal antibodies, which were excellent probes of enzyme function. However, they were in no w

...are linked to pendetide to chelate a [[radionuclide]], [[indium-111]]. The antibodies selectively bind to certain tumour cells, and the radioactivity is then use

...primary focus into the primary follicles [[follicular system]] and begin [[monoclonal]] expansion in the environment of [[follicular dendritic cell]]s (FDC). prevent the generation of autoreactive antibodies.<ref>{{cite journal | author=Thorbecke GJ, Amin AR, Tsiagbe VK| title=Biolo

...ganisms such as [[ELISA]] technology and the extensive use of [[monoclonal antibodies]]. The same year saw introduction of a new course, "Medical Defense Against